About

New York

Health Forum

The New York Health Forum was founded to strengthen healthcare partnerships and knowledge sharing around the world, supporting innovation and collaboration in global medicine and life sciences.

Following the motto scientia potentia est (“knowledge is power”), the NYHF brings together knowledge from industry experts, academia, medical and research facilities, service providers, financial investors, as well as policymakers to further the scope of healthcare. Expert knowledge has fueled unparalleled development of the health industry, and moreover has empowered the growth of one of the most rapidly changing fields of the 21st century.

By coalescing professionals of various backgrounds, the NYHF serves to foster discussion on the significant agendas and public concerns present in healthcare today, with the further goal of contributing to society and public health.

From the Chairman

Dear Colleagues and Friends,

I am pleased to see that our organization continues to build on its programs, innovate, and lead new initiatives in the ever expanding field of healthcare. We first established the New York Health Forum in response to the emerging needs in healthcare for mutual collaboration and multilateral connection.

Under the slogan, “Connecting to Improve Human Health,” the NYHF programs are designed to bring together industry executives, policymakers, bio-pharma scientists, as well as medical practitioners to discuss the next steps in the field. The multidisciplinary approach will help us realize the goal of achieving a healthier world through the effective use of scientific innovations, industry advancements, and policy implementations.

The NYHF is a platform for hands-on and face-to-face interactions between different health-related professions, and I welcome all of you to join us for this exciting journey in navigating towards a better healthcare.

Thank you for your support of the New York Health Forum.

Do Hyun Cho, PhD

Chairman of the New York Health Forum

President and CEO of W Medical Strategy Group

Our Past Panelists

Bob Ai, PhD, MBA

Managing Director,

Solebury Trout

Han Bang

Director,

CMIC USA

John Choi, MS

Project Director,

Enzychem Lifesciences

Kristin Booker

Writer,

Fashion.Style.Beauty

Frank Borchetta

CEO & Co-Founder,

Repairogen Corporation

Joseph H. Carabello

CEO, CPR

Strategic Marketing Communications

Tony Chen

CEO,

PrimeVax Immuno-Oncology, Inc.

Jon Civitarese

Managing Director,

SVB Leerink

Daniel Chain, PhD

President & CEO,

CereSpir, Inc.

Kara Dennis

Managing Director,

Medidata

Mark E. Dingle, MBA

CEO,

Care52

Marc Estigarribia, MBA

Managing Director,

MSQ Ventures

Les Funtleyder, MPH

Investment Manager,

Bluecloud Health

Kimberly Ha

Senior Director,

FTI Consulting

Katya Hancock

Director,

Strategic Partnership, StartUp Health

William Ho, MBA

President and CEO,

Incysus Therapeutics

SungHye Hwang, PhD, MBA

Corporate Affairs and Health & Value Director, Pfizer USA

Ariel Katz

Chief Product Officer,

Eunie Kim

Advisor,

C&R Research

Kun Chul Kim

U.S. Correspondent Reporter,

The Asia Business Daily

Sundeep Lal, PhD, MBA

CEO and Founder,

BioConnecxUs

Sangji Lee

Executive Director,

W Medical Stategy Group

Vincent Liu, PhD

Senior Advisor,

Fosun Pharma

Eddie Martucci, PhD

CEO and Co-Founder,

Akili Interactive

Woodson C. Merrell, MD

Executive Director,

Center for Health and Healing

Young Moon, MBA

Vice President,

BL&H USA

Cheryl A. Nickerson, PhD

Professor, Center for Fundamental and Applied Microbiomics, The Biodesign Institute, Arizona State University

Chul Kyoon Park

President,

it's a Wig

Sue Park

Branch Manager,

StyleKorean

Rich Poska, PharmD

CEO,

Flexo LLC

Allison Santhouse, PA-C

Clinician,

Schweiger Dermatology Group

Yiqin Shen

Senior Reporter,

Mergermarket

Larry Slatky

Chief Operating Officer,

NuHealth System

Se-joo Son

Consul General,

The Korean Consulate General New York

Bruce Thompson, MBA

Managing Partner,

WR Regulatory Services

Brent Vaughan

CEO,

Cognito Therapeutics

Ofra Weinberger, PhD

Director of Licensing,

Columbia Technology Ventures

Jaewook Yoo

Director,

KOTRA

Debra Yu

Managing Director,

Labrador Advisors

Jahan Ali, PhD

Director, BioVenture eLab at Weill Cornell Medical Center

John Bradley, MD

Managing Director,

Torreya Partners

Timothy M. Block, PhD

President&Professor, Baruch S. Blumberg Institute & the Hepatitis B Foundation

Karen Carr

Regional Development Officer,

Gateway for Cancer Research

Young Seok Byun, PhD

Head of R&D,

UK ChemiPharm

Han Choi, MD, LLM

Principal,

Oracle Investment Management

Anthony Chambers

Director, Life Sciences Practice,

West Monroe Partners

Jeff Clark, MD, JD

Chief Licensing Officer,

Enzychem Lifesciences

Edward Cox

EVP Strategic Alliances & Global Head of Digital Medicine, Eversana

Mark Dennish, MBA

Vice President,

Daiichi Sankyo(Japan)

Sean Drake

Managing Director,

Stony Lonesome Group LLC

Surani Fernando

Editor, North Amercia,

Biopharm Insight

Maria Gotsch, MBA

President and CEO,

Partnership Fund for New York City

Brian Harris

CEO and Co-Founder,

MedRhythms Inc.

Tony Handal, JD

Partner,

Greenspoon Marder

Marko Horvat

Vice President,

Financo Investment

Chul S. Hyun, MD, PhD

President,

World Korean Medical Organization

Keelin Kavanagh, JD

Managing Partner,

Jacob, Medinger & Finnegan, LLP

Howard Kim

Director of Business Development, Yonsung Fine Chemicals

Tae-wan Kim, PhD

Assoc. Prof, Pathology and Cell Biology, Columbia University Medical School

Bob Lee, MS

Former President,

HiOssen America

John R. Lieberman, CPA

Managing Director,

Perelson Weiner LLP

Michelle Longmire, MD

CEO and Co-Founder,

Medable

Jack McMackin

Founder,

Mission Innovation Network

Jamie Metzl, PhD, JD

Senior Fellow,

Atlantic Council

BongHyun Nam, MPH, PhD

Director,

Korean Ministry of Food and Drug Safety

Mark Ott, MBA, PhD

Microbiology Laboratory Lead, Johnson Space Center, NASA

Jinha Park, MD, PhD

Director, City of Hope Medical Center and Beckman Research Institute

Mark Paxton, JD, MS

FDA Sponsor's Representative,

US Army Medical R&D Command

Matthew Prepis

Director of Business Development, SmartSites

Mun-Sik Seol

Vice Governor,

Chungbuk Province

Shoshana Shendelman,

Partner and Managing Director,

Clearpoint Strategy Group

Jungmee Sohn, PhD

Manager, Foregin Investment Promotion, Chungbuk Provincial Government

Bryan Spielman, MBA

Executive Vice President, Strategy and Corporate Development, Medidata

Marc S. Ullman, JD

Of Counsel,

Rivkin Radler LLP

Joy Wang, PhD, MBA

US office head of Simcere Pharmaceuticals

Sherman Williams, MBA

Director of Investment Banking,

Chardan Capital Markets

Doug Yoon, MD, PhD, MBA

Senior advisor,

Exponent

Karen Yook

Manager of Business Operations,

W Medical Strategy Group

Imran Babar, PhD

Senior Associate,

OrbiMed LLC

Hana Ben-Shabat

Partner,

AT Kearney

David Blume

Managing Director,

Edgemont Capital Partners

Kathleen Broderick

U.S. Representative,

isoi Cosmetics

Laura Carabello

Principal, CPR

Strategic Marketing Communications

Robert Chu

CEO and Founder,

Embleema

Yeereum Chung, RN

Manager, Product Management,

W Medical Strategy Group

Peter Corless, JD

Partner,

Mintz Intellectual Property Practice

Alaric DeArment

Reporter,

BioPharm Insight

Yuan-Hua Ding, PhD

Executive Director & Head,

Asia/Pacific, Pfizer

Kathy Driscoll, RN, CCM

Strategic Executive,

Humana

G. Alexander Fleming, MD

Founder and CEO,

Kinexum Inc.

Kathryn Gregory, MBA

Executive Director,

Purdue Pharma L.P

Tae Sik Han

Director,

KOTRA

William C. Hicks, JD

Co-Chair, Mintz Securities and Capital Markets Practice Group

Scott Howell, MD, MPH&TM

Chief Medical Officer,

Tenet Diagnostics

Geoffrey Kaiser, JD

Counsel,

Rivkin Raddler LLP

Hiroyuki Kawabata

Director, Health and Welfare Department, JETRO New York

Judith Kim, JD

Chair of Intellectual Property Practice, Rubin and Rudman LLP

Kevin Kumler, MBA

Vice President,

ZocDoc

Kyoung-Ryul Lee, MD, PhD

Chairman,

Hanaro Medical Foundation

Jo-Wen Lin

Portfolio Manager,

Hudson Bay Capital

Peter Lyons

Chief Innovation Officer,

Atomic Capital

Joe McMenamin, MD, JD, FCLM

Vice President and CLO,

W Medical Strategy Group

Hideki Mitani

Senior Dean, The Institute of Medical Science, The university of Tokyo

Joseph Nam

Senior Associate,

Madison Bay Capital Partners

Rob Packard

Founder and President,

Medical Device Academy

Ji Sun Park, PhD

Senior Scientist,

Enzychem Lifesciences

William J. Polvino, MD

CEO and Director,

Bridge Medicines

James M Pusey, MD

SVP Clinical Operations,

Medpace Inc.

Steven Shapiro, JD

Of Counsel,

Rivkin Radler

Vahan Simonyan, PhD

Chief Scientist,

Embleema

Ki Young Sohn

CEO and Chairman,

Enzychem Lifesciences

Unity Stoakes

Co-founder and President,

StartUp Health

William R. Ventura, MD

Attending Physician,

St. Joseph Medical Center

Kenjiro Watanabe

Director, Business Development,

JETRO New York

Paula Wilson

President,

Joint Commission International(JCI)

Ji Soo Yoon, JD

Legal Counsel and Director,

W Medical Strategy Group

Norman Yun

Managing Director,

H.C Wainwright & Co.